<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen J</submitter><funding>NHLBI NIH HHS</funding><funding>U.S. Department of Defense</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Science Foundation</funding><pagination>193-206</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9957951</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>637</volume><pubmed_abstract>Nucleus targeting is tremendously important in cancer therapy. Cationic carbon dots (CCDs) are potential nanoparticles which might enter cells and penetrate nuclear membranes. Although some CCDs have been investigated in nucleus targeting and applied in nuclear imaging, the CCDs derived from drugs, that are able to target the nucleus, bind with DNA and inhibit the growth of cancer cells have not been reported. In this project, 1, 2, 4, 5-benzenetetramine (Y15, a focal adhesion kinase inhibitor) derived cationic carbon dots (Y15-CDs) were prepared via a hydrothermal approach utilizing Y15, folic acid and 1,2-ethylenediamine as precursors. Based on the structural, optical, and morphologic characterizations, Y15-CDs possess rich amine groups and nitrogen in structure, an excitation-dependent </pubmed_abstract><journal>Journal of colloid and interface science</journal><pubmed_title>Cancer cells inhibition by cationic carbon dots targeting the cellular nucleus.</pubmed_title><pmcid>PMC9957951</pmcid><funding_grant_id>SUB00002778</funding_grant_id><funding_grant_id>R21 CA250597</funding_grant_id><funding_grant_id>BC180657</funding_grant_id><funding_grant_id>R01HL156958</funding_grant_id><funding_grant_id>1R21CA250597</funding_grant_id><funding_grant_id>2041413</funding_grant_id><funding_grant_id>R01 HL156958</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Olivier JH</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Bartoli M</pubmed_authors><pubmed_authors>Tagliaferro A</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Domena JB</pubmed_authors><pubmed_authors>Leblanc RM</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Paulino V</pubmed_authors><pubmed_authors>Verde F</pubmed_authors><pubmed_authors>C L B Ferreira B</pubmed_authors><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Michael Brejcha N</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Luo L</pubmed_authors><pubmed_authors>Gu J</pubmed_authors><pubmed_authors>Arduino C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cancer cells inhibition by cationic carbon dots targeting the cellular nucleus.</name><description>Nucleus targeting is tremendously important in cancer therapy. Cationic carbon dots (CCDs) are potential nanoparticles which might enter cells and penetrate nuclear membranes. Although some CCDs have been investigated in nucleus targeting and applied in nuclear imaging, the CCDs derived from drugs, that are able to target the nucleus, bind with DNA and inhibit the growth of cancer cells have not been reported. In this project, 1, 2, 4, 5-benzenetetramine (Y15, a focal adhesion kinase inhibitor) derived cationic carbon dots (Y15-CDs) were prepared via a hydrothermal approach utilizing Y15, folic acid and 1,2-ethylenediamine as precursors. Based on the structural, optical, and morphologic characterizations, Y15-CDs possess rich amine groups and nitrogen in structure, an excitation-dependent </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-18T15:29:21.827Z</modification><creation>2025-04-07T02:10:20.757Z</creation></dates><accession>S-EPMC9957951</accession><cross_references><pubmed>36701865</pubmed><doi>10.1016/j.jcis.2023.01.086</doi></cross_references></HashMap>